Financials

  • Market Capitalization 39.16 M
  • Employee 15
  • Founded 1995
  • CEO N/A
  • Website www.cervomed.com
  • Headquarter Delaware, United States
  • FIGI BBG000N6JH48
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.96
Relación precio/flujo de caja
86.53

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4319
KPTI
Karyopharm Therapeutics Inc. - Common Stock
1.84 USD-0.54%-2.13%-5.15%-80.91%41.73 M USD
4338
ALGS
Aligos Therapeutics, Inc. - Common stock
6.19 USD+1.64%-13.91%+44.29%-36.77%38.61 M USD
4377
ACTU
Actuate Therapeutics, Inc. - Common stock
1.50 USD-2.60%-16.20%+31.58%-63.24%36.02 M USD
4390
RNAZ
TransCode Therapeutics, Inc. - Common Stock
2.03 USD-1.46%-17.14%-55.09%-78.65%34.37 M USD

Noticias